Company Overview of Nautilus Neurosciences, Inc.
Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company, engages in identifying and developing drugs for neurological disorders. It offers CAMBIATM, a prescription medicine for migraine attacks in adults. The company was incorporated in 2009 and is based in Bedminster, New Jersey.
135 Route 202/206
Bedminster, NJ 07921
Founded in 2009
Key Executives for Nautilus Neurosciences, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Nautilus Neurosciences, Inc., please visit www.nautilusneurosciences.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.